Drug intelligence / Profile preview

Yiganle capsules

Development stage
Unknown
Lead developer
Langzhi Group Shuangren Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Yiganle capsules are a traditional Chinese medicine (TCM) formulation primarily used for hepatoprotection and liver support. The active ingredient is typically gypenosides, which are saponins extracted from the plant *Gynostemma pentaphyllum*. The medication is indicated for the treatment of chronic hepatitis, fatty liver, and toxic liver injury, specifically to help reduce elevated transaminase levels and improve overall liver function. Its mechanism of action involves stabilizing hepatocyte membranes, reducing oxidative stress through free radical scavenging, and promoting protein synthesis within liver cells to aid regeneration. While Shuangren Pharmaceutical is associated with the distribution of this product, it is a widely available Chinese patent medicine produced by various manufacturers.

Brand names
益肝乐
Other names
Yiganle Jiaonang益肝乐胶囊
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on Yiganle capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiganle capsules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call